Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imma Forzano

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Medicine|December 11, 2025
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary InterventionImma Forzano, Domenico Florimonte, Viviana Narciso, et al.
International Journal of Cardiology. Heart & Vasculature|February 29, 2024
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII studyGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
Journal of Clinical Medicine|February 13, 2026
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary InterventionImma Forzano, Viviana Narciso, Mario Enrico Canonico, et al.
Cardiovascular Diabetology|October 3, 2025
Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trialDaniela Pacella, Maria Lembo, Valentina Trimarco, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII RegistryGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII studyGiuseppe Gargiulo, Viviana Narciso, Imma Forzano, et al.
Hypertension (Dallas, Tex. : 1979)|May 16, 2024
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of MetforminGaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2025
Correction: Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of MetforminGaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Journal of Cardiovascular Development and Disease|April 25, 2025
Procedural and Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Narrative ReviewDomenico Simone Castiello, Federica Buongiorno, Lina Manzi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Medicine|December 11, 2025
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary InterventionImma Forzano, Domenico Florimonte, Viviana Narciso, et al.
International Journal of Cardiology. Heart & Vasculature|February 29, 2024
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII studyGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
Journal of Clinical Medicine|February 13, 2026
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary InterventionImma Forzano, Viviana Narciso, Mario Enrico Canonico, et al.
Cardiovascular Diabetology|October 3, 2025
Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trialDaniela Pacella, Maria Lembo, Valentina Trimarco, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII RegistryGiuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, et al.
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII studyGiuseppe Gargiulo, Viviana Narciso, Imma Forzano, et al.
Hypertension (Dallas, Tex. : 1979)|May 16, 2024
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of MetforminGaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2025
Correction: Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of MetforminGaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Journal of Cardiovascular Development and Disease|April 25, 2025
Procedural and Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Narrative ReviewDomenico Simone Castiello, Federica Buongiorno, Lina Manzi, et al.
Pageof 3